Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.43 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.41 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PLG | P00747 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1886100 | 1.00 | GSR (0.43) | GSRRNPEPCPB2SLC6A5FOLH1 | |
| SCHEMBL32679718 | 0.98 | GSR (0.42) | GSRRNPEPCPB2SLC6A5FOLH1 | |
| SCHEMBL32679720 | 0.98 | GSR (0.42) | GSRRNPEPCPB2SLC6A5FOLH1 | |
| SCHEMBL32679719 | 0.98 | GSR (0.42) | GSRRNPEPCPB2SLC6A5FOLH1 | |
| SCHEMBL9716773 | 0.95 | CPB2 (0.38) | GSRRNPEPCPB2SLC6A5GRIK1 | |
| SCHEMBL9716770 | 0.95 | CPB2 (0.38) | GSRRNPEPCPB2SLC6A5GRIK1 | |
| SCHEMBL8931801 | 0.90 | SLC6A5 (0.45) | GSRRNPEPCPB2SLC6A5GRIK1 | |
| SCHEMBL8931799 | 0.90 | SLC6A5 (0.45) | GSRRNPEPCPB2SLC6A5GRIK1 | |
| SCHEMBL9314956 | 0.89 | SLC6A5 (0.47) | GSRCPB2SLC6A5GRIK1GRIK2 | |
| SCHEMBL1532638 | 0.89 | SLC6A5 (0.47) | GSRCPB2SLC6A5GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4859653-A | Use of compositions of matter containing N-acylates of alpha aminoacids for the treatment of skin | MORELLE JEAN V (FR) | 1989-08-22 | — | — | US | claimed |
| EP-4746847-A2 | COMPOSITION & METHODS FOR REGULATING MELANOGENESIS | Sytheon Ltd. (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-121586570-A | Compositions and methods for modulating melanogenesis | 赛泽恩有限公司 | 2026-02-27 | — | — | CN | disclosed |
| WO-2025019573-A2 | COMPOSITION & METHODS FOR REGULATING MELANOGENESIS | SYTHEON LTD. (US) | 2025-01-23 | — | — | WO | disclosed |
| US-12171852-B1 | Composition and methods for regulating melanogenesis | SYTHEON LTD (US) | 2024-12-24 | — | — | US | disclosed |
| US-9078864-B2 | Agonists for antimicrobial peptide systems | AKTHELIA PHARMACEUTICALS (IS) | 2015-07-14 | — | — | US | disclosed |
| US-20110118217-A1 | Agonists for Antimicrobial Peptide Systems | AKTHELIA PHARMACEUTICALS (IS) | 2011-05-19 | — | — | US | disclosed |
| EP-0178911-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1992-01-22 | — | — | EP | disclosed |
| EP-0178911-A2 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1986-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118217-A1 | Agonists for Antimicrobial Peptide Systems | VIP, GLP1R, MAVS | GSR 568/4885RNPEP 1174/4885CPB2 2511/4885 |
| US-12171852-B1 | Composition and methods for regulating melanogenesis | TYR, MITF, MC1R | GSR 2322/4885RNPEP 1244/4885CPB2 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.